SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 258,294.28 |
| Enterprise Value ($M) | 289,594.28 |
| Book Value ($M) | 46,905.00 |
| Book Value / Share | 18.48 |
| Price / Book | 5.51 |
| NCAV ($M) | -35,750.00 |
| NCAV / Share | -14.09 |
| Price / NCAV | -7.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.07 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.03 |
| Current Ratio | 1.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 29,977.00 |
| Assets | 104,469.00 |
| Liabilities | 65,727.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.96 | 7.58 | |
| 13G/A | BlackRock Inc. | 8.50 | 8.47 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S | ||
| Form 10-Q | ||
| Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 587,588 | 4,589,403 | 12.80 | |
| 673,476 | 5,590,039 | 12.05 | |
| 601,495 | 7,232,722 | 8.32 | |
| 318,618 | 4,758,881 | 6.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| JNJ – Johnson & Johnson | LCI – Lannett Co., Inc. |
| LLY – Lilly(Eli) & Co | MYOV – Myovant Sciences Ltd |
| NUVB – Nuvation Bio Inc – Class A |